Ratings by Barclays (Lukas Shumway)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/3/2026 | Alpha Tau Medical Ltd. | DRTS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/4/2026 | Alpha Tau Medical Ltd. | DRTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/28/2026 | Sutro Biopharma | STRO | New Coverage | Overweight (N/A) |
27.38 (19.34) |
-29.36% | Details | |
| 5/28/2026 | Immunome Inc. | IMNM | New Coverage | Overweight (N/A) |
21.91 (26.97) |
23.09% | Details | |
| 5/28/2026 | Cellectis | CLLS | New Coverage | Overweight (N/A) |
3.67 (3.12) |
-14.99% | Details | |
| 5/28/2026 | Alpha Tau Medical Ltd. | DRTS | New Coverage | Overweight (N/A) |
10.37 (14.92) |
43.88% | Details |
